The ability to provide stem cell treatments to patients is what we have all been working toward.
Miami (PRWEB) May 26, 2015
Regenestem Network has announced the grand opening of a new stem cells clinic in Buenos Aires, Argentina. The clinic will be lead by Silvina Pastrana, M.D., a renowned critical care specialist. Pastrana has assembled a multidisciplinary team of medical professionals who specialize in pulmonology, endocrinology and orthopedics in her state-of-the-art Puerto Madero office.
The new Regenestem Network members plan to operate phase I to phase IV clinical studies in cellular therapies, and establish Regenestem protocols to isolate and reintegrate adult autologous stem cells for therapeutic treatments.
“The Regenestem Network continues to grow internationally, and we are fortunate to have Dr. Pastrana on our team,” says Regenestem Founder and CEO Ricardo DeCubas. “Her expertise and that of her team, combined with Regenestem products, therapies and protocols is exactly what we need to make stem cell medicine available to a growing number of patients in the region.”
The new Buenos Aires facility offers the most advanced protocols and techniques available in stem cell medicine.
“I feel a sense of pride and excitement to have taken this step with Regenestem,” Pastrana says. “The ability to provide stem cell treatments to patients is what we have all been working toward, and I am very optimistic about the future.”
The Global Stem Cells Group and Regenestem are committed to the highest of standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of their international patients.
For more information, visit the Regenestem Network website, email info(at)regenstem(dot)com, or call 305-224-1858.
Regenestem Network, a division of the Global Stem Cells Group, Inc., is an international medical practice association committed to researching and producing comprehensive stem cell treatments for patients worldwide. Having assembled a highly qualified staff of medical specialists—professionals trained in the latest cutting-edge techniques in cellular medicine—Regenestem continues to be a leader in delivering the latest protocols in the adult stem cell arena. Global Stem Cells Group and Regenestem Network are expanding the company’s clinical presence worldwide by partnering with experienced and qualified regenerative medicine physicians to open new clinics licensed and developed under the Regenestem banner. In 2014, Global Stem Cells Group expanded the Regenestem Network’s global presence to 20 countries.
Regenestem offers stem cell treatments to help treat a variety of diseases and conditions including arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes, and pain due to injuries at various facilities worldwide. Regenestem Oaxaca will have an international staff experienced in administering the latest in cellular therapies.
Regenestem is certified for the medical tourism market, and staff physicians are board-certified or board-eligible. Regenestem clinics provide services in more than 10 specialties, attracting patients from the United States and around the world.
About the Global Stem Cell Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products, and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators, and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. With each of GSCG’s six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
To learn more about Global Stem Cells Group, Inc.’s companies and for investor information, visit the Global Stem Cell Group website, email bnovas(at)regenestem(dot)com, or call 305-224-1858.